透過您的圖書館登入
IP:52.14.121.242
本篇文章尚未正式出版,請點選「加入追蹤」跟進後續出版資訊!

並列摘要


NPC15199 is a synthesized compound that inhibits inflammation in some models. However, whether NPC15199 affects Ca^(2+) homeostasis in human gastric cancer is unclear. This study examined the effect of NPC15199 on cytosolic free Ca^(2+) concentrations ([Ca^(2+)]_i) and viability in SCM1 human gastric cancer cells. The Ca^(2+)-sensitive fluorescent dye fura-2 was used to measure [Ca^(2+)]_i. NPC15199 evoked [Ca^(2+)]_i rises concentration-dependently. The response was reduced by removing extracellular Ca^(2+). NPC15199-evoked Ca^(2+) entry was not inhibited by store-operated channel inhibitors (nifedipine, econazole and SKF96365) and protein kinase C (PKC) activator (phorbol 12-myristate 13 acetate, PMA), or PKC inhibitor (GF109203X). In Ca^(2+)-free medium, treatment with the endoplasmic reticulum Ca^(2+) pump inhibitor thapsigargin or 2,5-di-tert-butylhydroquinone (BHQ) nearly abolished NPC15199-evoked [Ca^(2+)]_i rises. Conversely, treatment with NPC15199 also nearly abolished thapsigargin or BHQ-evoked [Ca^(2+)]_i rises. Inhibition of phospholipase C (PLC) with U73122 did not affect NPC15199-evoked [Ca^(2+)]_i rises. NPC15199 at concentrations of 100-900 μM induced concentration-dependent, Ca^(2+)-independent decrease in viability. Together, in SCM1 cells, NPC15199 induced [Ca^(2+)]_i rises that involved Ca^(2+) entry through PKC-insensitive non-store-operated Ca^(2+) channels and PLC-independent Ca^(2+) release from the endoplasmic reticulum. NPC15199 also induced Ca^(2+)-independent cell death.

參考文獻


Badawi, A.F.,Eldeen, M.B.,Liu, Y.,Ross, E.A.,Badr, M.Z.(2004).Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferatoractivated receptor gamma.Cancer Res..64,1181-1189.
Bootman, M.D.,Berridge, M.J.,Roderick, H.L.(2002).Calcium signalling: more messengers, more channels, more complexity.Curr. Biol..12,R563-R565.
Burch, R.M.,Weitzberg, M.,Blok, N.,Muhlhauser, R.,Martin, D.,Farmer, S.G.,Bator, J.M.,Connor, J.R.,Ko, C.,Kuhn, W.,Mcmillan, B.A.,Raynor, M.,Shearer, B.G.,Tiffany, C.,Wilkins, D.E.(1991).N-(fluorenyl-9-methoxycarbonyl) amino acids, a class of antiinflammatory agents with a different mechanism of action.Proc. Natl. Acad. Sci. USA..88,355-359.
Burnstock, G.(2014).Burnstock, G. Purinergic signalling in the gastrointestinal tract and related organs in health and disease.Purinergic Signal..10,3-50.
Burnstock, G.,Di Virgilio, F.(2013).Purinergic signalling and cancer.Purinergic Signal..9,491-540.

延伸閱讀